Back to today’s briefing

Story perspectives

Genetic Breakthrough Offers Hope for Early Alzheimer’s Therapy

5/13/2025

23 2

Summary

Story summary

Mutations in the PSEN1, PSEN2, and APP genes have been linked to the early onset of familial Alzheimer’s disease, according to groundbreaking research. By examining amyloid-beta peptide production, scientists discovered that changes in peptide ratios can indicate when symptoms may begin. This insight opens doors for new therapies aimed at delaying Alzheimer’s in those genetically predisposed.

1 of 1

Story summary

Mutations in the PSEN1, PSEN2, and APP genes have been linked to the early onset of familial Alzheimer’s disease, according to groundbreaking research. By examining amyloid-beta peptide production, scientists discovered that changes in peptide ratios can indicate when symptoms may begin. This insight opens doors for new therapies aimed at delaying Alzheimer’s in those genetically predisposed.